Research workbench
Crystal structure of bombyx mori sigma-class glutathione transferase in apo form
Analyse Crystal structure of bombyx mori sigma-class glutathione transferase in apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3VPT
- Type
- protein
- Length
- 203 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Glutathione S-transferase sigma
- EC
- 2.5.1.18
- UniProt
- Q5CCJ4
- Pockets
- 1 · best druggability 0.52
Structure
x-ray diffraction · 1 distinct chain · 60% helix, 8% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Glutathione S-transferase sigma (EC 2.5.1.18) | protein | 203 | 60% helix, 8% strand | Q5CCJ4 |
Ligands and binding sites
- PGO · S-1,2-propanediol · additive · 6 copies · chains A
- PEG · Di(hydroxyethyl)ether · additive · 4 copies · chains A
- PG4 · Tetraethylene glycol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 133 | 0.52 | 0.80 | 21 | PGO |
Compared structures
- 3VPT · Crystal structure of Bombyx mori sigma-class glutathione transferase in apo form · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q5CCJ4
- Elsewhere: RCSB PDB 3VPT · PDBe 3VPT · UniProt Q5CCJ4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.